COVER LETTER

APPLICATION FOR DRUG REGISTRATION

Ref: ................................................
Applicant: Eurolife Healthcare Pvt. Ltd. India
Address: Plot No. B-15/2, MIDC Industrial Area, Waluj, Aurangabad-431136, INDIA
Post code: 431136 Town: Aurangabad, Maharashtra Country: INDIA
Date:
Reference:
The Secretary to the Authority,
National Drug Authority, Plot 19 Lumumba Avenue
P.O. Box 23096, Kampala, UGANDA
Phone: (+256) 41-255665 / 347391/ 347392
Fax: (+256) 41-255758
E-mail: ndaug@nda.or.ug
Subject: Submission of Application(s) for Marketing Authorization of GLUCOLIFE - (GLUCOSE
INTRAVENOUS INFUSION BP (5%w/v) 500 ML

Dear Sir,
We are pleased to submit our Application(s) for a registration of finished pharmaceutical product(s)
whose details are as follows:
Name of the finished pharmaceutical product(s): GLUCOLIFE - (GLUCOSE INTRAVENOUS
INFUSION BP (5%w/v) 500 ML

Pharmaceutical form(s) and strength(s): Intravenous Infusion and (5 % W/V) 500ml

INN/active substance(s): Anhydrous Glucose BP

ATC Code(s): B05BA03

You will find enclosed the submission dossier as specified hereafter:

CD rom; Quality Overall Summary and Bioequivalence Trial Information in word

format and body data in pdf format.
We confirm that all future submissions for this specific product will be submitted in
this same format.
We confirm that the electronic submission has been checked with an up-to-date and
state-of- the-art virus checker.

The relevant fees have been paid.

Yours sincerely,
Signature:

Name: Purva Arsekar

Title: Executive- Regulatory Affairs
Phone number: +22 42374211
Email address: purvaarsekar@eurolifehealthcare.com